Skip to main content

Replicel Life Sciences Inc (RP-X) Quote

Unchecking box will stop auto data updates
TSX Venture Real-Time Last Sale CAD
Today's Change
Volume
Price Quote as of

Today's Trading

Day Low 0.275
Day High 0.300
Open:0.290
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change

More stories below advertisement

FEATURE-EMPTY
Description
RepliCel Life Sciences Inc is a Canadian regenerative medicine company. It focuses on developing autologous cell therapies that treat functional cellular deficits. The company addresses various diseases such as chronic tendinosis, skin aging, and androgenetic alopecia. Its development program of the company is based on distinct technology which utilizes cells isolated from a patient's own healthy hair follicles. In addition, the company develops a programmable cell injector device designed for dermal injections of cells, dermal filler products, and a variety of other products injected through the skin. The treatments delivered by the company uses autologous cell therapy which is developed for the treatment of androgenetic alopecia.

Fundamentals

Market Capitalization, $M
Shares Outstanding, M
36-Month Beta
Earnings Per Share (TTM)
Revenue Growth YoY
Profit Margin
5-Year Avg. Revenue Growth
5-Year Avg. Profit Growth
1-Year Total Return
3-Year Total Return
5-Year Total Return
Price/Earnings (TTM)
Price/Earnings (Forward)
Trailing Annual Dividend & Yield
Forward Annual Dividend & Yield
Most Recent Dividend
Ex-Div Date
Most Recent Split
Return on Common Equity
Return-on-Assets (Before Tax)
Debt-to-Equity Ratio
Price/Book

Earnings

Corporate earnings are provided from Morningstar, including Income Statements,Balance Sheets, Cash Flow Statements, and Statement of Retained Earnings.

Analyst Research

Analyst Ratings and Earnings Estimates are provided by Zacks Investment Research – including Buy/Hold Recommendations, Earnings Surprises, Estimates and Recommendations History.

Stock Reports +

Download a comprehensive report detailing quantitative analytics of this equity. For subscribers only.

StockCalc Reports

Download a comprehensive report detailing quantitative analytics of this equity. For subscribers only.

Latest Press Releases

RepliCel Secures Several New Patents for its Regenerative Medicine Technologies
PR Newswire - Tue Apr 16, 5:00AM CDT
PR Newswire - CMTX
Tue Apr 16, 5:00AM CDT
Tendon Regeneration, Skin Rejuvenation and Dermal Injector Patents Granted in the United States, Europe, South Africa, Hong Kong, China, and Japan
RepliCel's Licensee Building Momentum in China with Facility and Team
PR Newswire - Tue Mar 26, 5:00AM CDT
PR Newswire - PRNW
Tue Mar 26, 5:00AM CDT
YOFOTO ( China ) Health Announces Initiation of Facility Build-Out, New Hires, and Preparation to Submit Applications to China's Regulators
RepliCel's Licensee Building Momentum in China with Facility and Team
PR Newswire - Tue Mar 26, 5:00AM CDT
PR Newswire - CMTX
Tue Mar 26, 5:00AM CDT
YOFOTO (China) Health Announces Initiation of Facility Build-Out, New Hires, and Preparation to Submit Applications to China's Regulators
Price History Describes more index sector components

Price Performance

Period Period Low Period High Performance
1-Month 0.260 +5.77% increase
on 08/01/19
Period Open:0.300
Price movement based on the high, low and last over the given period.
0.300 -8.33% decrease
on 08/15/19
-0.025 (-8.33%) decrease
since 07/15/19
3-Month 0.260 +5.77% increase
on 08/01/19
Period Open:0.360
Price movement based on the high, low and last over the given period.
0.390 -29.49% decrease
on 05/17/19
-0.085 (-23.61%) decrease
since 05/15/19
52-Week 0.260 +5.77% increase
on 08/01/19
Period Open:0.375
Price movement based on the high, low and last over the given period.
0.530 -48.11% decrease
on 09/24/18
-0.100 (-26.67%) decrease
since 08/15/18

More stories below advertisement

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2019.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).